- Patent expiries and the escalating demand for functionality excipients will help in building a robust growth structure for the pharmaceutical excipients market across the forecast period of 2019-2027
- The global market for pharmaceutical excipients, as predicted by Transparency Market Research (TMR) experts, will record a CAGR of ~5 percent between 2019 and 2027
ALBANY, N.Y., July 8, 2021 /PRNewswire/ --The pharmaceutical industry has grown at a mammoth speed over the years. The discovery and the utilization of certain drugs have increased exponentially. Drug development is a necessity in these times, where many diseases and infections are prevalent across many individuals. Excipients have a crucial role to play in the growth of the pharmaceutical excipients market. Therefore, the rising demand for excipients across the pharmaceutical industry will help in increasing the growth rate during the assessment period of 2019-2027.
Excipients have a pivotal role in the process of drug development. A wrong excipient choice can prove to be a blunder and even result in severe intoxications. The prominent function of an excipient is to act as a component or carrier of active substances in drugs. Active substances cannot be consumed directly. These substances, when fused with excipients, can be taken properly. In short, excipients assist in the manufacturing of the finished pharmaceutical product.
Transparency Market Research (TMR) has conducted comprehensive research on all the aspects related to the growth of the pharmaceutical excipients market. The information is compiled in the research report on the pharmaceutical excipients market. According to the market insights on the pharmaceutical excipients market by TMR experts, it is expected to expand at a CAGR of ~5 percent during the forecast period of 2019-2027. The global pharmaceutical excipients market was valued at US$ 6.9 bn in 2018 and is extrapolated to reach a valuation of ~US$ 10.7 bn by 2027, the end year of the forecast period.
The rising tendency among individuals to consume oral formulations and the expanding cases of chronic diseases will serve as growth-boosting factors for the global market for pharmaceutical excipients. The blend of active pharmaceutical ingredients with new excipients is proving to be a successful aspect for revenue-generation. The expansive focus on developing drug delivery systems will help increase the growth rate of the pharmaceutical excipients market.
Expiry of Blockbuster Drugs Patents will Invite Promising Growth for the Pharmaceutical Excipients Market
The market survey on pharmaceutical excipients highlights how the expiry of drug patents proves to be beneficial. A severe patent cliff can result in immense losses for drug companies and organizations. Patent cliff refers to a sudden drop in the sales of the products that are the highest revenue generators. This phenomenon is common in the pharmaceutical sector. Thus, the prevention of patent cliffs is crucial for any pharmaceutical organization or company. Hence, this factor bodes well for the growth of the pharmaceutical excipients market.
Mass Development of Orphan Drugs to Add Extra Stars of Growth
The research activities in orphan drugs have increased phenomenally due to the extensive funding initiatives by government bodies. The governments of numerous countries are focusing intensively on funding research initiatives. Treatment of rare diseases through oral formulations has gained considerable traction. These factors will help in improving the growth trajectory of the pharmaceutical excipients market considerably.
Pharmaceutical Excipients Market: Key Players
Some well-entrenched players in the pharmaceutical excipients market are:
Archer Daniels Midland Company
Croda International PLC
DuPont de Nemours, Inc.
Associated British Foods PLC
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Active Pharmaceutical Ingredients Market: Rise in prevalence of diseases & disorders and growth in government & organizational investments to develop APIs are major contributors to the expansion of the global active pharmaceutical ingredients (API) market
Drug Discovery Informatics Market: The global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."